PJP
Invesco Pharmaceuticals ETF
stockNYSEETF
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of pharmaceutical companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 23 U.S. pharmaceuticals companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 127.11 | 2026-09-28 | -4.88% | 1.266 |
| 1M | 129.15 | 2026-09-04 | -6.38% | 0.633 |
| 3M | 120.09 | 2026-07-06 | +0.68% | 0.231 |
| 6M | 102.75 | 2026-04-06 | +17.67% | 0.235 |
| 1Y | 95.19 | 2025-10-06 | +27.02% | 0.440 |
| 2Y | 86.38 | 2024-10-04 | +39.97% | — |
| 5Y | 76.90 | 2021-10-05 | +57.23% | 0.560 |
Invesco Pharmaceuticals ETF (NYSE:PJP) stock price today is $120.91, and today's volume is 21,601. PJP is down 0.272% today. The 30 day average volume is 37,241. PJP market cap is $541.68M with 4.48M shares outstanding.